By Saadia Aslam An FDA review of study findings showed a potential increased risk of cardiac arrhythmias in patients with pre-existing cardiac disease who are…
View More Lamotrigine may be associated with increased risk of cardiac arrhythmias, FDA warns
Dr Laura Dobson comments on a recent update by MHRA regarding fluoroquinolones.
View More Considerations for prescription of fluoroquinolones in patients developing signs or symptoms of heart valve disease
Drug Safety Update Published 17 December 2020From: Medicines and Healthcare products Regulatory Agency Erythromycin has been associated with events secondary to QT interval prolongation such…
View More Erythromycin: Caution required due to cardiac risks (QT interval prolongation); drug interaction with rivaroxaban